0001179110-20-008585.txt : 20200730 0001179110-20-008585.hdr.sgml : 20200730 20200730190304 ACCESSION NUMBER: 0001179110-20-008585 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200729 FILED AS OF DATE: 20200730 DATE AS OF CHANGE: 20200730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GILMAN STEVEN C CENTRAL INDEX KEY: 0001379970 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 201061749 MAIL ADDRESS: STREET 1: 110 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2020-07-29 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001379970 GILMAN STEVEN C C/O MOMENTA PHARMACEUTICALS, INC 301 BINNEY STREET CAMBRIDGE MA 02142 1 0 0 0 Common Stock 2020-07-29 4 M 0 10000 10.63 A 17796 D Common Stock 2020-07-29 4 S 0 10000 29.70 D 7796 D Stock Option (Right to Buy) 10.63 2020-07-29 4 M 0 10000 0 D 2018-06-22 2026-06-22 Common Stock 10000 13000 D This transaction was effected pursuant to a Rule 10b5-1 trading plan dated May 22, 2020 This transaction was executed in multiple trades at prices ranging from $29.20 to $30.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. /s/ R. Mark Chamberlin as attorney in fact 2020-07-30